FMR LLC

Position in FATE — Fate Therapeutics Inc

CIK 315066 BOSTON, MA

Back to FATE Full portfolio

Position in FATE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$57,108

+$44,608 QoQ

Shares Held

47,590

+273.1% QoQ

Ownership

0.041%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 5.162849338096239.ToString("F0")% Shared 0.ToString("F0")% None 94.83715066190376.ToString("F0")%

Common Shares in FATE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

FMR LLC holds $49,682,018,247 across 354 Biotechnology names. FATE ranks #262 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	14,579,166	$4,823,808,652
2	ARGX	Argenx SE	4,991,034	$3,644,702,577
3	MRNA	Moderna, Inc.	45,672,024	$2,320,138,818
4	ROIV	Roivant Sciences Ltd.	77,981,253	$2,160,080,705
5	INSM	INSMED Inc	13,160,167	$2,151,950,504
6	IONS	Ionis Pharmaceuticals Inc	24,556,637	$1,843,957,869
7	RPRX	Royalty Pharma plc	25,152,242	$1,206,553,046
8	REGN	Regeneron Pharmaceuticals, Inc.	1,518,192	$1,173,015,865

All Filings in FATE

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$57,108	47,590	+273.1%	Shares	Defined	2026-05-15
2025-12-31	$12,500	12,756	+21.7%	Shares	Defined	2026-02-17
2025-09-30	$13,209	10,484	-69.2%	Shares	Defined	2025-11-13
2025-06-30	$38,150	34,063	-41.2%	Shares	Defined	2025-08-14
2025-03-31	$45,738	57,897	-83.8%	Shares	Defined	2025-05-12
2024-12-31	$588,990	356,964	+56.6%	Shares	Defined	2025-02-13
2024-09-30	$797,933	227,981	+25.9%	Shares	Defined	2024-11-13
2024-06-30	$593,971	181,089	-29.2%	Shares	Defined	2024-08-13
2024-03-31	$1,876,440	255,646	-12.2%	Shares	Defined	2024-05-13
2023-12-31	$1,088,983	291,172	-5.3%	Shares	Defined	2024-02-13
2023-09-30	$652,175	307,630	-42.6%	Shares	Defined	2023-11-13
2023-06-30	$2,550,712	535,864	-15.4%	Shares	Defined	2023-08-11
2023-03-31	$3,608,823	633,127	+0.6%	Shares	Defined	2023-08-11
2022-12-31	$6,349,273	629,264	-57.0%	Shares	Defined	2023-02-13
2022-09-30	$32,764,876	1,462,065	+3.4%	Shares	Defined	2022-11-10
2022-06-30	$35,035,425	1,413,859	-12.5%	Shares	Defined	2022-08-12
2022-03-31	$62,641,309	1,615,716	-9.1%	Shares	Defined	2022-05-13
2021-12-31	$103,991,518	1,777,329	-21.0%	Shares	Defined	2022-02-14
2021-09-30	$133,324,899	2,249,450	-65.1%	Shares	Defined	2022-02-14
2021-06-30	$559,875,953	6,450,927	-22.5%	Shares	Defined	2021-08-13
2021-03-31	$686,701,397	8,328,701	+9.5%	Shares	Defined	2021-05-14
2020-12-31	$691,513,920	7,604,904	+9.1%	Shares	Defined	2021-02-08
2020-09-30	$278,653,572	6,971,568	+10.0%	Shares	Defined	2020-11-13
2020-06-30	$217,423,259	6,337,023	-7.9%	Shares	Defined	2020-08-24
2020-03-31	$152,842,179	6,881,683	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.